Fundamentals

Valuation

Metric	Q2	Q3	Δ in %
EV/EBITDA	10.96	275.60	248.38
Graham Fair Price	-30.15	1.17	1.67
PEG	381.04	-5.35	1.11
Price/Book	24.84	1.43	1.14
Price/Cash Flow	0.00	0.00	0.00
Prices/Earnings	72.83	216.50	125.27
Price/Sales	91.98	11.19	5.83
Price/FCF	0.00	0.00	0.00
Naive Interpretation	member

01 - Valuation · Bad

Fundamentals

Profitability

Metric	Q2	Q3	Δ in %
Gross Profit Margin	-43.07	0.26	0.45
Operating Margin	-173.01	-0.03	< 0.005
ROA	-24.15	< 0.005	< 0.005
ROE	< 0.005	< 0.005	-27.77
ROIC	< 0.005	< 0.005	10.66
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q2	Q3	Δ in %
Debt QOQ	-1.00	0.00	-100.00
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	0.74	-0.78	5.76
EPS QOQ	1.13	-0.40	-64.07
FCF QOQ	0.00	0.00	0.00
Revenue QOQ	0.43	-0.35	-20.13
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q2	Q3	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	0.00	0.00
Days Sales Outstanding (DSO)	94.30	0.00	inf
Inventory Turnover	0.00	0.00	0.00
Debt/Capitalization	0.10	0.00	inf
Quick Ratio	2.31	1.75	-24.24
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q2	Q3	Δ in %
Book Value	7.39	6.07	-17.81
Cash	2.75	1.88	-31.61
Capex	n.A.	n.A.	n.A.
Free Cash Flow	n.A.	n.A.	n.A.
Revenue	1.45	0.77	-46.55
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q2	Q3	Δ in %
Current Ratio	2.35	2.86	21.63
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	23.04	-75.15	226.16
Naive Interpretation	Member

06 - Financial Health · Bad

Rating